Related references
Note: Only part of the references are listed.Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
DNA supercoiling and transcription in bacteria: a two-way street
Charles J. Dorman
BMC MOLECULAR AND CELL BIOLOGY (2019)
Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study
Xiaozhou Fan et al.
GUT (2018)
Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
Vrishketan Sethi et al.
GASTROENTEROLOGY (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Effect of preoperative biliary drainage on bacterial flora in bile of patients with periampullary cancer
F. Scheufele et al.
BRITISH JOURNAL OF SURGERY (2017)
Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients
Claire L. Gorrie et al.
CLINICAL INFECTIOUS DISEASES (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Quinolones in the Search for New Anticancer Agents
Pedro Netto Batalha et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
Antoine Grillon et al.
PLOS ONE (2016)
Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods
Mamun-Ur Rashid et al.
CLINICAL INFECTIOUS DISEASES (2015)
Recurrent antibiotic exposure may promote cancer formation - Another step in understanding the role of the human microbiota?
Ben Boursi et al.
EUROPEAN JOURNAL OF CANCER (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Risks associated with the therapeutic use of fluoroquinolones
Ralf Stahlmann et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Gatifloxacin Induces S and G2-Phase Cell Cycle Arrest in Pancreatic Cancer Cells via p21/p27/p53
Vikas Yadav et al.
PLOS ONE (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells
I. Fabian et al.
BRITISH JOURNAL OF CANCER (2006)
Redefining the R1 resection in pancreatic cancer
C. S. Verbeke et al.
BRITISH JOURNAL OF SURGERY (2006)
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells
C Herold et al.
BRITISH JOURNAL OF CANCER (2002)
The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis
U Adam et al.
INFECTION (2001)
Share Paper
